Your browser doesn't support javascript.
loading
First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005-2015).
Wang, Daniel Y; Li, Abby; Paes, Bosco; Mitchell, Ian; Lanctôt, Krista L.
Afiliação
  • Wang DY; Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Room FG-21, Toronto, ON, M4N 3M5, Canada.
  • Li A; Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Room FG-21, Toronto, ON, M4N 3M5, Canada.
  • Paes B; Department of Pediatrics, McMaster University, Hamilton, ON, Canada.
  • Mitchell I; Department of Pediatrics, University of Calgary, Calgary, AB, Canada.
  • Lanctôt KL; Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Room FG-21, Toronto, ON, M4N 3M5, Canada. krista.lanctot@sunnybrook.ca.
Eur J Pediatr ; 176(3): 413-422, 2017 Mar.
Article em En | MEDLINE | ID: mdl-28105526

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Infecções por Vírus Respiratório Sincicial / Palivizumab / Pneumopatias Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Male / Newborn País como assunto: America do norte Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Infecções por Vírus Respiratório Sincicial / Palivizumab / Pneumopatias Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Male / Newborn País como assunto: America do norte Idioma: En Ano de publicação: 2017 Tipo de documento: Article